Protalix BioTherapeutics (PLX)
(Delayed Data from AMEX)
$1.14 USD
+0.03 (2.70%)
Updated Jun 18, 2024 04:00 PM ET
After-Market: $1.14 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | 0.02 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | NA |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.12 |
Next Year | 0.63 |
EPS (TTM) | 0.04 |
P/E (F1) | 9.50 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 12.50M | 16.26M | 52.71M | 101.44M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 12.50M | 16.26M | 52.71M | 101.44M |
Low Estimate | 12.50M | 16.26M | 52.71M | 101.44M |
Year ago Sales | 35.08M | 10.35M | 65.49M | 52.71M |
Year over Year Growth Est. | -64.37% | 57.10% | -19.52% | 92.45% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.02 | 0.06 | 0.12 | 0.63 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | 0.02 | 0.06 | 0.12 | 0.63 |
High Estimate | 0.02 | 0.06 | 0.12 | 0.63 |
Low Estimate | 0.02 | 0.06 | 0.12 | 0.63 |
Year ago EPS | 0.21 | -0.04 | 0.09 | 0.12 |
Year over Year Growth Est. | -90.48% | 250.00% | 33.33% | 425.00% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.02 | 0.06 | 0.12 | 0.63 |
7 Days Ago | 0.02 | 0.06 | 0.12 | 0.63 |
30 Days Ago | 0.02 | 0.06 | 0.12 | 0.63 |
60 Days Ago | NA | NA | 0.21 | 0.81 |
90 Days Ago | NA | NA | 0.21 | 0.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.02 | 0.06 | 0.12 | 0.63 |
Zacks Consensus Estimate | 0.02 | 0.06 | 0.12 | 0.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.07 | -0.04 | 0.21 | NA |
Estimate | NA | -0.03 | -0.07 | -0.04 | NA |
Difference | NA | -0.04 | 0.03 | 0.25 | 0.08 |
Surprise | NA | -133.33% | 42.86% | 625.00% | 178.18% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more